Sun Pharmaceutical Industries
Sun Pharmaceutical Industries Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and commercialization of healthcare products. The enterprise produces a broad range of branded generic formulations, complex unbranded generics, over-the-counter medicines, and active pharmaceutical ingredients. Its therapeutic portfolio addresses chronic and acute conditions in cardiology, psychiatry, neurology, gastroenterology, dermatology, and oncology. Revenue is primarily driven by pharmaceutical formulations sales across India, the United States, and diverse emerging international markets. The firm holds the market position as India's largest specialty generic pharmaceutical enterprise by revenue and prescription market share. Sun Pharmaceutical Industries is headquartered in Mumbai, India, and is listed on the National Stock Exchange of India and the BSE Limited.
31 of the funds FundTelligence covers report a position in Sun Pharmaceutical Industries.
- Legal name
- SUN PHARMACEUTICAL INDUSTRIES LTD
- Sector
- Health Care
- Country
- India
- Funds holding it
- 31
Funds holding Sun Pharmaceutical Industries
- HSBC GIF Indian Equity — HSBC Asset Management · 3.97 % (largest positions only, June 2026)
- Fidelity India Focus Fund — Fidelity · 3.5 % (largest positions only, October 2026)
- BNP India Equity — BNP Paribas · 1.96 % (full portfolio disclosed, June 2026)
- GS India Equity — Goldman Sachs · 1.95 % (largest positions only, September 2026)
- Carnegie Indienfond — Carnegie · 1.38 % (full portfolio disclosed, June 2026)
- DNB Fund India — DNB · 1.29 % (full portfolio disclosed, September 2026)
- Indecap Guide Tillväxtmarknadsfond — Indecap · 1.05 % (full portfolio disclosed, June 2026)
- Schroder ISF Healthcare Innovation — Schroders · 0.83 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 31 funds holding it.